Annual CFF
$0.00
-$75.00 K-100.00%
31 December 2023
Summary:
Cardiff Oncology annual cash flow from financing activities is currently $0.00, with the most recent change of -$75.00 thousand (-100.00%) on 31 December 2023. During the last 3 years, it has fallen by -$137.31 million (-100.00%). CRDF annual CFF is now -100.00% below its all-time high of $137.31 million, reached on 31 December 2020.CRDF Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$7.43 M
+$5.37 M+260.88%
30 September 2024
Summary:
Cardiff Oncology quarterly cash flow from financing activities is currently $7.43 million, with the most recent change of +$5.37 million (+260.88%) on 30 September 2024. Over the past year, it has increased by +$7.43 million (+100.00%). CRDF quarterly CFF is now -92.55% below its all-time high of $99.76 million, reached on 31 December 2020.CRDF Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$9.59 M
+$7.43 M+343.05%
30 September 2024
Summary:
Cardiff Oncology TTM cash flow from financing activities is currently $9.59 million, with the most recent change of +$7.43 million (+343.05%) on 30 September 2024. Over the past year, it has increased by +$9.59 million (+100.00%). CRDF TTM CFF is now -93.01% below its all-time high of $137.31 million, reached on 31 December 2020.CRDF TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRDF Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.0% | +100.0% | +100.0% |
| 3 y3 years | -100.0% | +100.0% | -92.0% |
| 5 y5 years | -100.0% | +398.2% | +25.6% |
CRDF Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | -50.4% | -92.0% | |||
| 5 y | 5 years | -100.0% | -92.5% | -93.0% | |||
| alltime | all time | -100.0% | +100.0% | -92.5% | +144.6% | -93.0% | +172.5% |
Cardiff Oncology Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $7.43 M(+260.9%) | $9.59 M(+343.0%) |
| June 2024 | - | $2.06 M(+1823.4%) | $2.17 M(+1923.4%) |
| Mar 2024 | - | $107.00 K(>+9900.0%) | $107.00 K(>+9900.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2023 | - | $0.00(0.0%) | $0.00(-100.0%) |
| June 2023 | - | $0.00(0.0%) | $75.00 K(0.0%) |
| Mar 2023 | - | $0.00(0.0%) | $75.00 K(0.0%) |
| Dec 2022 | $75.00 K(-99.8%) | $0.00(-100.0%) | $75.00 K(-99.5%) |
| Sept 2022 | - | $75.00 K(>+9900.0%) | $15.04 M(+0.5%) |
| June 2022 | - | $0.00(0.0%) | $14.96 M(-56.2%) |
| Mar 2022 | - | $0.00(-100.0%) | $34.19 M(-3.6%) |
| Dec 2021 | $35.45 M(-74.2%) | $14.96 M(>+9900.0%) | $35.45 M(-70.5%) |
| Sept 2021 | - | $0.00(-100.0%) | $120.25 M(-9.3%) |
| June 2021 | - | $19.23 M(+1422.2%) | $132.57 M(-2.6%) |
| Mar 2021 | - | $1.26 M(-98.7%) | $136.12 M(-0.9%) |
| Dec 2020 | $137.31 M(+1036.9%) | $99.76 M(+709.1%) | $137.31 M(+227.0%) |
| Sept 2020 | - | $12.33 M(-45.8%) | $41.99 M(+34.8%) |
| June 2020 | - | $22.77 M(+827.1%) | $31.16 M(+175.9%) |
| Mar 2020 | - | $2.46 M(-44.7%) | $11.29 M(-6.5%) |
| Dec 2019 | $12.08 M(-26.4%) | $4.44 M(+197.8%) | $12.08 M(+58.1%) |
| Sept 2019 | - | $1.49 M(-48.7%) | $7.64 M(+24.3%) |
| June 2019 | - | $2.90 M(-10.4%) | $6.15 M(-66.5%) |
| Mar 2019 | - | $3.24 M(>+9900.0%) | $18.35 M(+11.9%) |
| Dec 2018 | $16.40 M(-357.2%) | $0.00(0.0%) | $16.40 M(-19.9%) |
| Sept 2018 | - | $0.00(-100.0%) | $20.47 M(-23.7%) |
| June 2018 | - | $15.11 M(+1069.0%) | $26.84 M(-644.6%) |
| Mar 2018 | - | $1.29 M(-68.2%) | -$4.93 M(-22.7%) |
| Dec 2017 | -$6.38 M | $4.07 M(-36.1%) | -$6.38 M(-39.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | $6.37 M(-138.2%) | -$10.51 M(-20.5%) |
| June 2017 | - | -$16.66 M(>+9900.0%) | -$13.22 M(-655.3%) |
| Mar 2017 | - | -$156.50 K(+158.3%) | $2.38 M(+3.5%) |
| Dec 2016 | $2.30 M(-96.4%) | -$60.60 K(-101.7%) | $2.30 M(-34.1%) |
| Sept 2016 | - | $3.66 M(-445.2%) | $3.49 M(-90.9%) |
| June 2016 | - | -$1.06 M(+349.0%) | $38.39 M(-10.0%) |
| Mar 2016 | - | -$236.00 K(-120.9%) | $42.63 M(-34.0%) |
| Dec 2015 | $64.55 M(+345.7%) | $1.13 M(-97.1%) | $64.55 M(+1.7%) |
| Sept 2015 | - | $38.56 M(+1111.2%) | $63.48 M(+154.7%) |
| June 2015 | - | $3.18 M(-85.3%) | $24.93 M(-31.2%) |
| Mar 2015 | - | $21.68 M(>+9900.0%) | $36.21 M(+150.0%) |
| Dec 2014 | $14.48 M(-37.0%) | $61.30 K(>+9900.0%) | $14.48 M(+0.6%) |
| Sept 2014 | - | $0.00(-100.0%) | $14.39 M(-60.2%) |
| June 2014 | - | $14.47 M(<-9900.0%) | $36.20 M(+58.3%) |
| Mar 2014 | - | -$48.60 K(+64.7%) | $22.87 M(-0.5%) |
| Dec 2013 | $22.98 M(+50.0%) | -$29.50 K(-100.1%) | $22.98 M(-16.1%) |
| Sept 2013 | - | $21.81 M(+1811.5%) | $27.39 M(+390.5%) |
| June 2013 | - | $1.14 M(+1615.5%) | $5.58 M(-61.5%) |
| Mar 2013 | - | $66.50 K(-98.5%) | $14.50 M(-5.4%) |
| Dec 2012 | $15.32 M(+495.5%) | $4.38 M(<-9900.0%) | $15.32 M(+27.6%) |
| Sept 2012 | - | -$500.00(-100.0%) | $12.01 M(-4.3%) |
| June 2012 | - | $10.06 M(+1030.6%) | $12.55 M(+338.2%) |
| Mar 2012 | - | $889.50 K(-16.4%) | $2.86 M(+11.2%) |
| Dec 2011 | $2.57 M(+48.4%) | $1.06 M(+98.8%) | $2.57 M(+70.4%) |
| Sept 2011 | - | $535.00 K(+42.7%) | $1.51 M(+54.9%) |
| June 2011 | - | $375.00 K(-37.5%) | $975.00 K(+62.5%) |
| Mar 2011 | - | $600.00 K | $600.00 K |
| Dec 2010 | $1.73 M | - | - |
FAQ
- What is Cardiff Oncology annual cash flow from financing activities?
- What is the all time high annual CFF for Cardiff Oncology?
- What is Cardiff Oncology annual CFF year-on-year change?
- What is Cardiff Oncology quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Cardiff Oncology?
- What is Cardiff Oncology quarterly CFF year-on-year change?
- What is Cardiff Oncology TTM cash flow from financing activities?
- What is the all time high TTM CFF for Cardiff Oncology?
- What is Cardiff Oncology TTM CFF year-on-year change?
What is Cardiff Oncology annual cash flow from financing activities?
The current annual CFF of CRDF is $0.00
What is the all time high annual CFF for Cardiff Oncology?
Cardiff Oncology all-time high annual cash flow from financing activities is $137.31 M
What is Cardiff Oncology annual CFF year-on-year change?
Over the past year, CRDF annual cash flow from financing activities has changed by -$75.00 K (-100.00%)
What is Cardiff Oncology quarterly cash flow from financing activities?
The current quarterly CFF of CRDF is $7.43 M
What is the all time high quarterly CFF for Cardiff Oncology?
Cardiff Oncology all-time high quarterly cash flow from financing activities is $99.76 M
What is Cardiff Oncology quarterly CFF year-on-year change?
Over the past year, CRDF quarterly cash flow from financing activities has changed by +$7.43 M (+100.00%)
What is Cardiff Oncology TTM cash flow from financing activities?
The current TTM CFF of CRDF is $9.59 M
What is the all time high TTM CFF for Cardiff Oncology?
Cardiff Oncology all-time high TTM cash flow from financing activities is $137.31 M
What is Cardiff Oncology TTM CFF year-on-year change?
Over the past year, CRDF TTM cash flow from financing activities has changed by +$9.59 M (+100.00%)